Byeong-Gon Lee

Title: Byeong-Gon Lee: Innovator in Health Food Technology

Introduction

Byeong-Gon Lee is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of health food technology, particularly through his innovative research and development of novel strains of bacteria.

Latest Patents

One of his key patents is for the Lactobacillus brevis G-101 strain and its use. This invention relates to a novel G-101 strain capable of decomposing monosodium L-glutamate (MSG). The patent outlines a functional health food, a pharmaceutical composition, or a food product that includes this strain as an active ingredient. More specifically, the strain is effective in reducing in vivo blood MSG levels in animals and attenuating MSG Symptom Complex. This makes it a valuable addition to products aimed at preventing the harmful absorption of MSG and improving related symptoms.

Career Highlights

Byeong-Gon Lee has been instrumental in advancing research in the health food sector. His work has led to the development of innovative solutions that address health concerns associated with MSG consumption. His dedication to improving public health through scientific research is commendable.

Collaborations

He has collaborated with notable colleagues, including Hong Ryeol Jeon and Yoon-Mo Kang, to further enhance the impact of his research and inventions.

Conclusion

Byeong-Gon Lee's contributions to health food technology through his patented Lactobacillus brevis G-101 strain exemplify his commitment to innovation and public health. His work continues to pave the way for advancements in functional foods and pharmaceuticals.